Fig. 4From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinibRelationship among the combination of total cholesterol and low density lipoprotein (coTC-LDL) scoring groups with PFS and OS (PA = 0.000, PB = 0.017, PC = 0.000, PD = 0.012)Back to article page